Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Publication year range
1.
Biochem Pharmacol ; 194: 114819, 2021 12.
Article in English | MEDLINE | ID: mdl-34757034

ABSTRACT

Although treatments for allergic diseases have improved, side effects and treatment resistance remain as challenges. New therapeutic drugs for allergic diseases are urgently required. Thymic stromal lymphopoietin (TSLP) is a cytokine target for prevention and treatment of allergic diseases. Since TSLP is produced from epithelial cells in allergic diseases, TSLP inhibitors may be new anti-allergic drugs. We previously identified a new inhibitor of TSLP production, named 16D10. However, its target of action remained unclarified. In this study, we found proteins binding to 16D10 from 24,000 human protein arrays by AlphaScreen-based high-throughput screening and identified bromodomain and extra-terminal (BET) family proteins as targets. We also clarified the detailed mode of interaction between 16D10 and a BET family protein using X-ray crystallography. Furthermore, we confirmed that inhibitors of BET family proteins suppressed TSLP induction and IL-33 and IL-36γ expression in both mouse and human keratinocyte cell lines. Taken together, our findings suggest that BET family proteins are involved in the suppression of TSLP production by 16D10. These proteins can contribute to the pathology of atopic dermatitis via TSLP regulation in keratinocytes and have potential as therapeutic targets in allergic diseases.


Subject(s)
Chalcones/metabolism , Chalcones/pharmacology , Cytokines/antagonists & inhibitors , Keratinocytes/drug effects , Keratinocytes/metabolism , Nerve Tissue Proteins/metabolism , Receptors, Cell Surface/metabolism , Animals , Cell Line , Chalcones/chemistry , Crystallography, X-Ray , Cytokines/biosynthesis , Dose-Response Relationship, Drug , Humans , Mice , Mice, Inbred BALB C , Protein Binding/physiology , Protein Structure, Secondary , Thymic Stromal Lymphopoietin
2.
Yakugaku Zasshi ; 133(6): 727-36, 2013.
Article in Japanese | MEDLINE | ID: mdl-23728096

ABSTRACT

  Although progesterone vaginal suppositories (hospital-formulated) are used for the treatment of infertility, their half-life is so short that multiple doses are required. In this study, we aimed to develop sustained-release vaginal suppositories suitable for clinical use which maintain an effective blood concentration by once-a-day treatment, and prepared 7 types of suppository containing the sustained-release progesterone tablets to characterize their sustained-release performance. We selected one candidate suppository among them, taking recovery rate, reproducibility, and hardness, as well as the sustained-release performance into consideration. The shell of the selected suppository is composed of VOSCO S-55 and progesterone for rapid release. The molded progesterone tablets for sustained release were embedded inside. The distribution of the weight and content of the suppository was limited, and the release rate of progesterone was significantly slower than that of a conventional progesterone suppository prepared in our hospital. The single-dose administration of the selected suppository to five healthy volunteers led to significant extension of the blood concentration. We also confirmed the rise of the basic value by multiple administration. The simulation comparison suggested that the blood progesterone concentration is controlled by once-a-day administration of the selected suppository better than twice-a-day administration of the conventional suppository. In conclusion, the sustained-release vaginal suppository prepared in this study was considered to be useful for clinical treatment.


Subject(s)
Fertility Agents, Female/administration & dosage , Formularies, Hospital as Topic , Progesterone/administration & dosage , Progesterone/blood , Progestins/administration & dosage , Adult , Delayed-Action Preparations , Feasibility Studies , Female , Fertility Agents, Female/blood , Humans , Luteal Phase/blood , Menopause/blood , Middle Aged , Progestins/blood , Suppositories
3.
J Vet Med Sci ; 68(2): 119-23, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16520532

ABSTRACT

The effects of hyaluronic acid, which comprises the cumulus intercellular matrix, on Ca(2+) influx, lactate dehydrogenase (LDH) activity, and cyclic AMP synthesis in canine sperm during capacitation was investigated. Ejaculated sperm were collected from 10 Beagle dogs and the sperm were incubated for 4 hr in Eagle's MEM containing 10 microg/ml of hyaluronic acid. The percentages of actively motile sperm, hyperactivated sperm (HA-sperm), acrosome-reacted sperm (AR-sperm), and sperm labeled with fluoresceinated Ca(2+) indicator (Ca(2+)-labeled sperm) were evaluated to assess Ca(2+) influx into the sperm. LDH activity and cAMP concentration were measured in homogenized sperm. The mean percentages of motile sperm, HA-sperm, and Ca(2+)-labeled sperm in the MEM containing hyaluronic acid were higher than in the control medium (P<0.05, 0.05, and 0.01, respectively), but there was no difference between the percentages of AR-sperm. Mean LDH activity and mean cAMP concentration were also significantly higher than the control values (P<0.05). The percentages of HA-sperm correlated with those of Ca(2+)-labeled sperm (r(2)=0.810). The results indicate that hyaluronic acid increases Ca(2+) influx, LDH activity, and cAMP synthesis in canine ejaculated sperm during capacitation in vitro.


Subject(s)
Calcium/metabolism , Cyclic AMP/biosynthesis , Dogs/physiology , Hyaluronic Acid/pharmacology , L-Lactate Dehydrogenase/metabolism , Sperm Capacitation/drug effects , Spermatozoa/drug effects , Acrosome Reaction/drug effects , Animals , Male , Microscopy, Fluorescence/veterinary , Sperm Motility/drug effects , Spermatozoa/enzymology , Spermatozoa/metabolism , Spermatozoa/physiology
SELECTION OF CITATIONS
SEARCH DETAIL